DekaBank Deutsche Girozentrale’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-120,000
| Closed | -$498K | – | 1498 |
|
|
2023
Q2 | $498K | Buy |
120,000
+3,400
| +3% | +$14.1K | ﹤0.01% | 1027 |
|
|
2023
Q1 | $737K | Hold |
116,600
| – | – | ﹤0.01% | 938 |
|
|
2022
Q4 | $840K | Hold |
116,600
| – | – | ﹤0.01% | 924 |
|
|
2022
Q3 | $1.07M | Hold |
116,600
| – | – | ﹤0.01% | 862 |
|
|
2022
Q2 | $843K | Hold |
116,600
| – | – | ﹤0.01% | 915 |
|
|
2022
Q1 | $1.5M | Buy |
116,600
+10,600
| +10% | +$136K | ﹤0.01% | 824 |
|
|
2021
Q4 | $1.8M | Buy |
106,000
+2,900
| +3% | +$49.4K | ﹤0.01% | 798 |
|
|
2021
Q3 | $1.69M | Buy |
103,100
+30,000
| +41% | +$490K | ﹤0.01% | 758 |
|
|
2021
Q2 | $1.02M | Hold |
73,100
| – | – | ﹤0.01% | 904 |
|
|
2021
Q1 | $1.07M | Buy |
73,100
+35,000
| +92% | +$511K | ﹤0.01% | 886 |
|
|
2020
Q4 | $645K | Sell |
38,100
-1,900
| -5% | -$32.2K | ﹤0.01% | 970 |
|
|
2020
Q3 | $733K | Buy |
+40,000
| New | +$733K | ﹤0.01% | 845 |
|
|
2019
Q4 | – | Sell |
-41,400
| Closed | -$848K | – | 1154 |
|
|
2019
Q3 | $848K | Sell |
41,400
-44,000
| -52% | -$901K | 0.01% | 700 |
|
|
2019
Q2 | $1.84M | Buy |
85,400
+64,100
| +301% | +$1.38M | 0.01% | 643 |
|
|
2019
Q1 | $426K | Buy |
21,300
+3,600
| +20% | +$72K | ﹤0.01% | 932 |
|
|
2018
Q4 | $156K | Sell |
17,700
-3,600
| -17% | -$31.7K | ﹤0.01% | 1003 |
|
|
2018
Q3 | $426K | Sell |
21,300
-600
| -3% | -$12K | ﹤0.01% | 954 |
|
|
2018
Q2 | $323K | Hold |
21,900
| – | – | ﹤0.01% | 985 |
|
|
2018
Q1 | $245K | Sell |
21,900
-500
| -2% | -$5.59K | ﹤0.01% | 967 |
|
|
2017
Q4 | $258K | Hold |
22,400
| – | – | ﹤0.01% | 917 |
|
|
2017
Q3 | $258K | Hold |
22,400
| – | – | ﹤0.01% | 923 |
|
|
2017
Q2 | $324K | Hold |
22,400
| – | – | ﹤0.01% | 892 |
|
|
2017
Q1 | $459K | Buy |
+22,400
| New | +$459K | ﹤0.01% | 748 |
|
|
2016
Q3 | – | Sell |
-22,400
| Closed | -$376K | – | 971 |
|
|
2016
Q2 | $376K | Buy |
22,400
+5,700
| +34% | +$95.7K | ﹤0.01% | 735 |
|
|
2016
Q1 | $321K | Buy |
+16,700
| New | +$321K | ﹤0.01% | 743 |
|